InvestorsHub Logo
Followers 0
Posts 130
Boards Moderated 0
Alias Born 07/22/2009

Re: None

Wednesday, 05/12/2010 1:49:06 PM

Wednesday, May 12, 2010 1:49:06 PM

Post# of 552
Looks good, should run till June 5th results on the drug trial. Im excited, big short interest % for extra fuel!

BOSTON (MarketWatch) -- Shares of Poniard Pharmaceuticals /quotes/comstock/15*!pard/quotes/nls/pard (PARD 1.29, +0.04, +3.20%) moved up 14% to $1.18 Monday afternoon. Poniard said that it plans to release Phase III data from a lung-cancer clinical trial for its chemotherapy agent picoplatin on June 5 at the annual meeting of the American Society of Clinical Oncology.

GLTA